External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

NASAOS 2026

-
Coming soon
10:30 PM
Duration 15mins California, USA
Primary Results of the Phase 3 SatraGO-1 and SatraGO-2 Trials: Efficacy and Safety of Satralizumab in Thyroid Eye Disease
Prem Subramanian

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar